Maternal arterial desaturation with 15-methyl prostaglandin F2 alpha for uterine atony
Hankins, G.D.; Berryman, G.K.; Scott, R.T.; Hood, D.
Obstetrics and Gynecology 72(3 Part 1): 367-370
1988
ISSN/ISBN: 0029-7844 PMID: 3261408 Document Number: 316852
Over a six-month period, five women with severe uterine atony and postpartum hemorrhage developed marked maternal arterial oxygen desaturation within five to ten minutes of the administration of 15-methyl prostaglandin F2 alpha. The average fall from baseline was 10.4 +/- 5.4%, to a mean arterial oxygen saturation of 88.8 +/- 5.45%. The desaturation was accompanied by acute increases, averaging 20.7 +/- 5.9%, in the intrapulmonary shunt.
Document emailed within 1 workday
Related Documents
Høgdall, E.V.; Høgdall, C.K. 1991: 15(S)-15-methyl-prostaglandin F2 alpha. a potent synthetic prostaglandin F2 alpha for treatment of postpartum atony Ugeskrift for Laeger 153(46): 3260-3262Hayashi, R.H.; Castillo, M.S.; Noah, M.L. 1981: Management of severe postpartum hemorrhage due to uterine atony using an analogue of prostaglandin F2 alpha Obstetrics and Gynecology 58(4): 426-429
Tsalacopoulos, G.; Bloch, B.; Rush, J.M. 1982: Intramuscular and extra-amniotic 15-(S)-15-methyl-prostaglandin F2 alpha in intra-uterine death South African Medical Journal 61(22): 825-828
Perry, K.G.; Roberts, W.E.; Martin, R.W.; Magann, E.F.; Sullivan, D.L.; Morrison, J.C. 1998: Comparison of intra-amniotic (15S)-15-methyl-PGF2 alpha and intravaginal prostaglandin E2 for second-trimester uterine evacuation Journal of Perinatology: Official Journal of the California Perinatal Association 18(1): 24-27
Boes, E.G. 1980: Missed abortion, hydatidiform mole and intra-uterine fetal death treated with 15-methyl-prostaglandin F 2-alpha South African Medical Journal 58(22): 878-880
Sethi, A.; Jalnawalla, S.F. 1979: Termination of second trimester pregnancy with single intra-amniotic and extra-amniotic instillation of prostaglandin F2 alpha and 15-methyl prostaglandin F2 alpha Journal of Obstetrics and Gynaecology of India 29(2): 274-282
Wang, Y.F.; Jin, Y.C.; Wu, Y.E.; Gu, L.J.; Xie, X.H. 1989: The cervix-ripening effect of 15-methyl-prostaglandin F2 alpha methyl ester before vacuum aspiration for termination of early pregnancy in primigravidae Chinese Medical Journal 102(3): 200-202
Watanabe, K.; Iguchi, Y.; Iguchi, S.; Arai, Y.; Hayaishi, O.; Roberts, L.J. 1986: Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase Proceedings of the National Academy of Sciences of the United States of America 83(6): 1583-1587
Southern, E.M. 1976: Preliminary trials of vaginal silastic devices containing (15s)-15 methyl prostaglandin f2 alpha methyl ester for the induction of menses and for pregnancy termination summary of brook lodge workshop (January 29, 1976) Prostaglandins 12(Suppl): 147-152
Tsalacopoulos, G. 1978: Intra-uterine extra-amniotic prostaglandin F2-alpha in the management of patients with intra-uterine fetal death South African Medical Journal 53(21): 848-852
Romanovich, A.I.; Chizhov, O.S.; Sviridov, A.F. 1988: Synthetic studies in the series of polyene macrolide antibiotics. 5. Synthesis of methyl-2,4,6-trideoxy-2,4-di-C-methyl-alpha-L- gluco-hexopyranoside and methyl-2,4,6-trideoxy-2,4-di-C-methyl- alpha-L-manno-hexopyranoside, the stereoisomers of the C33-C38 fragment of amphotericin B Bioorganicheskaia Khimiia 14(8): 1109-1112
Caminiti, F.; De Murtas, M.; Parodo, G.; Lecca, U.; Marongiu, M.E.; La Colla, P.; Nasi, A. 1980: Metabolic changes induced by 15(S) 15-methyl prostaglandin F2 alpha in tumoral cells European Journal of Gynaecological Oncology 1(2): 112-115
Kovavisarch, E.; Kosolkittiwong, S. 1997: Bimanual uterine compression as a major technique in controlling severe postpartum hemorrhage from uterine atony Journal of the Medical Association of Thailand 80(4): 266-269
Göretzlehner, G.; Rudolf, K.; Frahm, R. 1977: Therapeutic induction of abortion in the 1st and 2nd trimesters with intramuscular 15-methyl-prostaglandin F2 alpha Zentralblatt für Gynakologie 99(22): 1356-1360
Novak-Antolic, Z.; Assejev, V. 1982: Induction of abortion in the second trimester of pregnancy by intramuscular 15-methyl prostaglandin F 2 alpha (Prostin 15M) Clinical and Experimental Obstetrics and Gynecology 9(1): 4-6
During, R.; Mauck, I.; Schwarzlos, G. 1977: Blood coagulation studies of therapeutic abortion induced by 15-methyl-prostaglandin F2 alpha Zentralblatt für Gynakologie 99(22): 1361-1365
Rajan, R.; Subhadra, N.M.; Sarada, A.K.; Usha, D.L.; John, R. 1979: Evaluation of a lower dose schedule of intramuscular 15(S)-15-methyl prostaglandin F2 alpha for induction of early midtrimester abortion Journal of Obstetrics and Gynaecology of India 29(1): 38-43
Rajan, R.; Subhadra, N.M.; Sarada, A.K.; Usha, D.L.; John, R. 1979: Evaluation of a lower dose schedule of intramuscular 15(S)-15-methyl prostaglandin F2 alpha for induction of early midtrimester abortion Journal of Obstetrics and Gynaecology of India 29(1): 38-43
McCracken, J.A.; Schramm, W.; Barcikowski, B.; Wilson, L. 1981: The identification of prostaglandin F2 alpha as a uterine luteolytic hormone and the hormonal control of its synthesis Acta Veterinaria Scandinavica. Supplementum 77: 71-88
Høgdall, C.K.; Høgdall, E. 1989: Treatment of severe postpartum atony with prostaglandin Ugeskrift for Laeger 151(38): 2410-2413